NCT04364334

Brief Summary

Rationale: In view of patient care, patient characteristics and treatment parameters are registered for all patients visiting the Mobility Clinic of the University Medical Center Utrecht for orthopaedic knee treatment. Patients also fill out questionnaires for function, pain and mobility of the knee, before and after treatment. Objective: The main objective of this registry is to collect patient characteristics and treatment parameters together with data from the questionnaires in a database. This knee registry can be used for future research questions. Study design: This is a longitudinal observational registry. Study population: All patients that visit the Mobility Clinic will be asked to participate in the knee registry. Patients that meet one or more of the following criteria will be excluded: are below the age of 16, not able or willing to sign the broad consent form, not being able to read and understand Dutch language, or receiving medical treatment for their knee elsewhere. Main study parameters/endpoints: Data will be collected for future research for which the purpose is not known at this time. When new research will be conducted, study parameters will be set. A study application has to be submitted to the institutional ethical review board of the University Medical Center Utrecht. Patients do not need to be asked permission for the use of their data for each study individually. Only when additional information is needed. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The burden for patients to participate in this registry is minimal and consists of time. Any future results may be beneficial for patients. Participation or refusal to participate in the registry has no consequences for their treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000,000

participants targeted

Target at P75+ for all trials

Timeline
897mo left

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jan 2017Jan 2100

Study Start

First participant enrolled

January 1, 2017

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

April 15, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 28, 2020

Completed
79.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2100

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2100

Last Updated

December 5, 2023

Status Verified

November 1, 2023

Enrollment Period

83.1 years

First QC Date

April 15, 2020

Last Update Submit

November 28, 2023

Conditions

Keywords

Knee

Outcome Measures

Primary Outcomes (12)

  • Patient characteristics and medical data

    General patient characteristics, medical data, and specific knee data.

    Status at baseline.

  • Change in EQ5D (EuroQol 5 dimensions)

    The EQ-5D-5L is a questionnaire about the quality of life on a scale of 0-100 and has 5 dimensions, each dimension has 5 levels. A higher score indicates a higher health utility. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflect the patient's own judgement.

    Before treatment, and after treatment at 3, 6, 9 (only for ACI patients) and 12 months. Then annually up to 20 years.

  • Change in KOOS (Knee Injury and Osteoarthritis Outcome Score)

    Questionnaire for evaluating limitations and symptoms for patients with knee complaints. Scale of 0-100, where 100 indicates no symptoms and limitations and 0 an extreme amount of symptoms and limitations.

    Before treatment, and after treatment at 3, 6, 9 (only for ACI patients) and 12 months. Then annually up to 20 years.

  • Change in IKDC (International Knee Documentation Committee)

    Questionnaire about symptoms and function for patients with knee complaints. Scale of 0-100 where 100 indicates the highest level of function and lowest level of symptoms.

    Before treatment, and after treatment at 3, 6 and 12 months. Then annually up to 20 years.

  • Change in SF-36

    Questionnaire about the health related quality of life. There are several subcategories on a scale of 0-100, where a higher score indicates a better health related quality of life.

    Before treatment, and after treatment at 3, 6 and 12 months. Then annually up to 20 years.

  • Change in VAS pain (Visual Analogue Scale)

    Question about pain on on a horizontal visual analogue scale, where the endpoints are labelled 'no pain' and 'unbearable pain'. This is converted into a scale of 0-100 where a higher score indicates a higher level of pain.

    Before treatment, and after treatment at 3, 6 and 12 months. Then annually up to 20 years.

  • Change in NRS pain (Numeric Rating Scale)

    Question about the pain on a scale of 0 to 10 during rest and activity. 0 indicating no pain, 10 indicating extreme pain.

    Before treatment, and after treatment at 3, 6, 9 (only for ACI patients) and 12 months. Then annually up to 20 years.

  • Change in Tegner

    Question about the level of work and sports activity on a scale from 0 to 10, where 10 indicates a high level of activity.

    Before treatment, and after treatment at 3, 6 and 12 months. Then annually up to 20 years.

  • Anker questions

    Questions about the results of surgery for functionality, pain and satifaction. Descriptive.

    After treatment at 3, 6 and 12 months

  • Change in OKS (Oxford knee score)

    Questionnaire about the pain and limitations of activities for patients with a knee prosthesis. Maximal total score is 60, indicating the maximum level of pain or functional limitations.

    Before treatment, and after treatment at 3, 6 and 12 months. Then annually up to 20 years.

  • Change in healthcare use and costs

    iMTA-questionnaire descriptive (Medical Consumption and Productivity Cost Questionnaire)

    Before treatment, and after treatment at 6, 9 (only for ACI patients) and 12 months.

  • Change in KOOS-PS (Knee Injury and Osteoarthritis Outcome Score-short form)

    Short form of the questionnaire for evaluating limitations and symptoms for patients with knee complaints. Scale of 0-100, where 100 indicates no symptoms and limitations and 0 an extreme amount of symptoms and limitations.

    Before treatment, and after treatment at 3, 6 and 12 months. Then annually up to 20 years.

Study Arms (1)

Knee registry patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients that visit the Mobility Clinic at the UMC Utrecht for their knee pathology.

You may qualify if:

  • Receives orthopaedic knee surgery or conservative knee treatment (advice, physiotherapy, injections etc) at the UMC Utrecht;
  • Able to read and understand Dutch language;
  • Is able and willing to signs the broad consent form.

You may not qualify if:

  • Receives no treatment (refusal of surgery or treatment);
  • Receives treatment elsewhere.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Utrecht

Utrecht, 3584 CX, Netherlands

RECRUITING

Related Links

MeSH Terms

Conditions

Osteoarthritis, KneeOsteochondritis Dissecans

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesOsteochondritisBone Diseases

Study Officials

  • Roel Custers, Dr

    Orthopedic surgeon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
20 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 15, 2020

First Posted

April 28, 2020

Study Start

January 1, 2017

Primary Completion (Estimated)

January 1, 2100

Study Completion (Estimated)

January 1, 2100

Last Updated

December 5, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

New research questions that requires data from the registry need to be discussed and approved by the PI and data manager/coordinator of this registry. The proposal should also be in agreement with the research collaboration and data transfer guidelines and agreements of the UMC Utrecht. Proposals need to be submitted to the institutional ethical review board of the University Medical Center Utrecht. After review, the data selection will be provided to the researcher.

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
In view of the regulation for clinical trials, the investigators need to save all data for at least 15 years with the goal to be able to go back to patient level. After finishing the project all documents and data are stored at the UMC Utrecht.
Access Criteria
The data manager keeps the linking table to personal data.

Locations